# Arxis (ARXS)

Sector: Aerospace & defense components

| Field | Value |
|---|---|
| Price | $48.46 |
| Market cap | $21B |
| Intrinsic value source | AI estimate |
| Data as of | 2026-11-20 |
| Next earnings | 2027-01-28 (estimate) |

Analysts: Very bullish

Picks: Research only

Discount category: Far above intrinsic value

## In short

Investors pay a premium for the high margins and acquisition plan of Arxis, and only organic growth near its 2027 guidance with acquisitions at fair prices can earn this price.

## Themes and gap

- Themes: High debt (leverage), Interest rates (interest-rates)
- Gap type: Slow (slow)
- Why: The premium depends on several years of organic growth and acquisitions at fair prices, so each quarterly report adds evidence slowly through 2027 and later.

## About

Arxis, Inc. (ARXS) is a US company that designs and makes proprietary electronic and mechanical components for mission-critical uses. Its products include connectors, sensors, bearings, seals, ceramic packages for electronics and flexible driveshafts. It has two segments, Electronic Components and Mechanical Components. In Q3 2026, defense and space gave about 45% of revenue, industrial technology about 33% and commercial aerospace about 22%. Arxis grows by buying smaller component makers, and it bought six companies in the first nine months of 2026, among them Omnetics. Arcline Investment Management formed Arxis, and funds of Arcline hold all Class B shares, which have 98.7% of the voting power. Arxis completed its IPO on the Nasdaq in April 2026, and its headquarters are in Bloomfield, Connecticut.

## Thesis

The market prices Arxis above the AI estimate, because it pays for a business that it expects to grow earnings for many years, like other owners of proprietary aerospace parts. Arxis reported organic growth of 28.7% and an adjusted EBITDA margin of 45.4% in Q3 2026, and it guides 2027 adjusted EBITDA of $1,010 million to $1,060 million. It also buys small component makers, such as Omnetics and MagCanica for about 12 times their estimated 2027 adjusted EBITDA. The AI estimate is lower because the organic growth of 2026 is above the 10% to 15% that Arxis guides for 2027, and goodwill and intangible assets were $6,151 million at September 30, 2026. Arcline controls the company, and a resale prospectus registers 13,351,964 shares of the former owners of Omnetics. For the price to hold, organic growth must stay at 10% or more, the adjusted EBITDA margin must stay above 40%, and acquisitions must keep adding EBITDA at fair prices without much new debt. The evidence arrives with the Q4 2026 results in about late January 2027, where 2026 revenue must be inside the guidance of $2,050 million to $2,070 million, and with the 2027 quarters. If growth and margins hold through 2027, the business can grow into the price over several years. If defense or aerospace demand slows, the price can fall toward the AI estimate.

## Checkpoints

- Jan 28, 2027 (estimate): Q4 2026 results and 2027 guidance. Status: Pending. Watch: 2026 revenue inside or above $2,050 million to $2,070 million and adjusted EBITDA inside or above $855 million to $865 million pass; a miss or lower 2027 guidance fails.
- 2027 (estimate): Organic growth in 2027. Status: Pending. Watch: Organic growth inside the guided 10% to 15% with an adjusted EBITDA margin above 42% passes; organic growth below 10% fails.

## Valuation

The intrinsic value for Arxis is an AI estimate from November 14, 2026. It is not an analyst's value. An AI research agent calculated it from the filings of Arxis. The method is a multiple of 2027 adjusted EBITDA, less net debt, divided by a diluted share count, in three cases. The release of October 28, 2026 gives 2027 guidance of revenue of $2,400 million to $2,500 million and adjusted EBITDA of $1,010 million to $1,060 million, and 2026 guidance of adjusted EBITDA of $855 million to $865 million. It gives adjusted EBITDA of $772.7 million for the 12 months to September 30, 2026, and net debt of $1,240.0 million at that date, from total debt of $1,718.7 million, unamortized financing costs of $14.9 million and cash of $493.7 million. The low case assumes 2027 adjusted EBITDA of $980 million, below the guidance, at 14 times. The base case assumes $1,035 million, the midpoint of the guidance, at 19 times. The high case assumes $1,100 million, with more acquisitions, at 24 times. The EBITDA of the low and high cases, the multiples and the weights of 25%, 50% and 25% are assumptions. The 10-Q of October 29, 2026 gives 90,045,099 Class A shares and 340,676,783 Class B shares outstanding at September 30, 2026, which have the same economic rights. The estimate adds all 10.1 million unvested restricted shares and RSUs, although some restricted shares can be in the share count already. It also adds about 5.4 million shares for the convertible common stock of Arcline, which can convert from April 2031 into 1.25% of the fully diluted shares multiplied by a factor that depends on the share price. These additions are assumptions, so the total is about 446.3 million shares. The estimate does not subtract the Jacksonville guarantee, for which Arxis accrued $21.0 million, or future payments under the tax receivable agreement with Arcline. The base case gives $41.29 per share, the low case $27.97 and the high case $56.38. The weighted value is $41.73 per share. Arxis reported an adjusted EBITDA margin of 45.4% and organic growth of 28.7% in Q3 2026, and its parts are often designed into long aircraft and defense programs. But a large part of its value comes from acquisitions: goodwill and intangible assets were $6,151 million at September 30, 2026.

As of 2026-11-14.

Sources:

- https://www.sec.gov/Archives/edgar/data/2093536/000119312526437000/arxs-20260930.htm
- https://www.sec.gov/Archives/edgar/data/2093536/000119312526436169/arxs-ex99_1.htm
- https://www.sec.gov/Archives/edgar/data/2093536/000119312526419718/arxs-20261013.htm

## Balance sheet

- Cash: $494M
- Debt: $1.7B
- Net debt: $1.2B
- EBITDA, last 12 months: $773M
- Net debt / EBITDA: 1.6× (low)
- Undrawn credit line: $396M
- Last debt due: 2032

At September 30, 2026, Arxis had cash and cash equivalents of $493.7 million. Total debt was $1,718.7 million on the balance sheet, or $1,733.6 million before unamortized financing costs, mostly the 2025 Term Loan due 2032 with an effective interest rate of 5.9%. Net debt was $1,240.0 million, or 1.6 times adjusted EBITDA of $772.7 million for the last 12 months, down from 4.2 times at December 31, 2025. In April 2026, Arxis used $946.0 million of its IPO proceeds to prepay the term loan. The $400 million revolving credit facility had no balance, and $396.3 million was available. Interest rate collars with a cap of 5.0% covered a notional amount of $1,779.0 million. Goodwill was $3,206.5 million, intangible assets were $2,944.6 million and stockholders' equity was $5,350.0 million.

As of 2026-09-30.

Sources:

- https://www.sec.gov/Archives/edgar/data/2093536/000119312526437000/arxs-20260930.htm
- https://www.sec.gov/Archives/edgar/data/2093536/000119312526436169/arxs-ex99_1.htm

## Dividends

Arxis does not pay a dividend.

Source: company filings and market data, read on 2026-11-13.

## Recent events

- 2026-10-28: Arxis reported Q3 2026 results. Revenue rose 36% to $564 million, with 29% organic growth, net income was $84 million and adjusted EBITDA rose 67% to $256 million. Arxis raised its 2026 guidance to revenue of $2,050 million to $2,070 million and gave 2027 guidance of revenue of $2,400 million to $2,500 million.
- 2026-10-13: Arxis filed a resale prospectus for up to 13,351,964 Class A shares that the former owners of Omnetics received.
- 2026-09-02: Arxis bought Schatz Bearing, a maker of precision bearings. In September it also bought StratEdge, a maker of ceramic packages for high-frequency electronics, and the two deals cost about $151 million together.
- 2026-08-17: Arxis completed the purchase of Omnetics Connector Corporation, at an agreed enterprise value of about $770 million, and paid with 13,351,964 new Class A shares.
- 2026-07-29: Arxis reported Q2 2026 results. Revenue rose 25% to $501 million and adjusted EBITDA rose 38% to $211 million. It raised its 2026 guidance and completed the purchase of Blue Line Engineering.
- 2026-06-02: Arxis agreed to buy Omnetics in an all-stock deal and said that it bought MagCanica, a maker of torque sensors, on June 1, 2026. The combined price was about $890 million, or about 12 times estimated 2027 adjusted EBITDA.
- 2026-05-27: Arxis reported Q1 2026 results, its first as a public company. Revenue rose 21% to $459 million, and net income was $53 million.
- 2026-04-16: Arxis completed its IPO of 46,575,000 Class A shares, with net proceeds of $1,220.6 million, and used $946.0 million to prepay part of its term loan.
- 2026-01-05: Arxis bought Micro-Tronics, a maker of elastomeric and metal components for aerospace and defense.

## Latest news and filings

- Last earnings: 2026-10-28
- Next earnings: 2027-01-28 (expected; the company has not confirmed it)

| Filed | Form | Headline | Period end | XBRL document | Link |
| --- | --- | --- | --- | --- | --- |
| 2026-10-29 | 10-Q | Quarterly report for the period ended Sep 30, 2026 | 2026-09-30 | arxs-20260930 | https://www.sec.gov/Archives/edgar/data/2093536/000119312526437000/arxs-20260930.htm |
| 2026-10-28 | 8-K | Current report |  | arxs-20261028 | https://www.sec.gov/Archives/edgar/data/2093536/000119312526436169/arxs-20261028.htm |
| 2026-08-18 | 8-K | Acquisition or sale completed |  | arxs-20260818 | https://www.sec.gov/Archives/edgar/data/2093536/000119312526354774/arxs-20260818.htm |
| 2026-07-30 | 10-Q | Quarterly report for the period ended Jun 30, 2026 | 2026-06-30 | arxs-20260630 | https://www.sec.gov/Archives/edgar/data/2093536/000119312526325027/arxs-20260630.htm |
| 2026-07-29 | 8-K | Earnings release |  | arxs-20260729 | https://www.sec.gov/Archives/edgar/data/2093536/000119312526323755/ |
| 2026-06-02 | 8-K | New material agreement and Other company news |  | arxs-20260529 | https://www.sec.gov/Archives/edgar/data/2093536/000119312526252459/arxs-20260529.htm |
| 2026-05-28 | 8-K | Earnings release |  | arxs-20260527 | https://www.sec.gov/Archives/edgar/data/2093536/000119312526243574/ |
| 2026-05-28 | 10-Q | Quarterly report for the period ended Mar 31, 2026 | 2026-03-31 | arxs-20260331 | https://www.sec.gov/Archives/edgar/data/2093536/000119312526243043/arxs-20260331.htm |
| 2026-04-17 | 8-K | New material agreement and Acquisition or sale completed |  |  | https://www.sec.gov/Archives/edgar/data/2093536/000119312526161805/d15141d8k.htm |

Every filing on SEC EDGAR (CIK 2093536): https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002093536&type=&dateb=&owner=include&count=40

## Risks

- High: Funds of Arcline control the company, which uses the controlled company exemptions of Nasdaq. Arcline also receives 85% of certain tax savings under a tax receivable agreement, and its convertible common stock can convert into new shares from April 2031.
- Medium: Growth depends on acquisitions. Goodwill and intangible assets were $6,151 million at September 30, 2026, and they can lose value if acquired companies do not perform.
- Medium: Total debt was $1,718.7 million at September 30, 2026, mostly a term loan due 2032 with an effective interest rate of 5.9%, and net leverage was 1.6 times.
- Medium: Arxis guarantees a long-term customer contract of a business in Jacksonville, Florida, that it sold in November 2024. The customer alleges damages of $48.3 million or more, and Arxis accrued $21.0 million at September 30, 2026.
- Low: Sales to foreign customers were about 33.9% of revenue in 2025, and some suppliers are in other countries, so tariffs and trade rules can affect sales and costs.

## Links

- Page: https://picks.utilarium.app/company/ARXS/
- History of changes: https://picks.utilarium.app/company/ARXS/history/
- JSON with full history: https://picks.utilarium.app/data/company/ARXS.json

> Picks is a personal record of stock picks. It gives general opinions about stocks, including a "Top pick" label. They are not tailored to your needs, goals or risk tolerance. Kevin is not a registered adviser and relies on the general-advice exemption in Canadian securities law (NI 31-103 s.8.25). Do your own research, or ask a registered adviser. Kevin may hold any stock on this site. Prices, intrinsic values and ratings can be delayed or wrong; check the original source. Full disclaimer: /disclaimer/.
